Funding Rounds
Cambridge Epigenetix

Cambridge Epigenetix Series D (2021, $88M)

Cambridge Epigenetix

Platform using epigenetics to simplify routine diagnostic tests for common cancers to a simple blood draw.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series D

Raised Amount: $88.00M

Raised Date: 2021-01-01